7° Congresso Nazionale

REFERENCES
1. Reich O, Gratzke C, Stief CG. Techniques and long-term results of
surgical procedures for BPH. Eur Urol 2006; 49:970-978.
2. Burnett AL, Wein AJ. Benign prostatic hyperplasia in primary care:
what you need to know. J Urol 2006; 175:S19-24.
3. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transuerthral
prostatectomy: immediate and postoperative complications. A cooperative
study of 13 participating institutions evaluating 3.885 patients. J
Urol 1989; 141:243-247.
4. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate
and postoperative complications of transurethral prostatectomy in the
1990s. J Urol 1999; 162:1307-1310.
5. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of
transurethral resection of the prostate (TURP)-incidence, management,
and prevention. Eur Urol 2006; 50:969-980.
6. Lynch M, Anson K. Time to rebrand transurethral resection of the
prostate? Curr Opin Urol 2006; 16:20-24.
7. de la Rosette J, Alivizatos G, Madersbacher S, et al. EAU guidelines
on benign prostatic hyperplasia (BPH). Eur Urol 2001; 40:256-263.
8. AUA Practice Guideline Committee. AUA guidelines on management
of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and
treatment recommendations. J Urol 2003; 170:530-547.
9. Brehmer M and Nilsson BY. Elevation of sensory thresholds in the
prostatic urethra after microwave thermotherapy. Br J Urol Int 2000;
86:427-431.
10. Bolmsjo M, Wagrell L, Hallin A, et al. The heat is on but how? A
comparison of TUMT devices Br J Urol 1996; 78:564-572.
11. Hoffman RM, McDonald R, Monga M, Wilt TJ. Transurethral
microwave thermotherapy vs. transurethral resection for treating
benign prostatic hyperplasic: a systematic review. Br J Urol Int 2004;
94:1031-1036.
12. Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, et al. Longterm
follow-up of randomized transurethral microwave thermotherapy
versus transurethral prostatic resection study. J Urol 2001; 165:
1533-1538.
13. Norby B, Nielsen HV, Frimodt-Moller PC. Transurethral interstitial
laser coagulation of the prostate and transurethral microwave thermotherapy
vs. transurethral resection or incision of the prostate: results
of a randomized, controlled study in patients with symptomatic benign
prostatic hyperplasia. Br J Urol Int 2002; 90: 853-862.
14. Wagrell L, Schelin S, Nordling J et al. Feedback microwave thermotherapy
versus TURP for clinical BPH a randomized controlled
multicentre study. Urology 2002; 60:292- 299.
15. Mattiasson A, Schelin S, Magnusson B, et al. Coretherm ® treatment
vs. TURP in patients with BPH: a prospective randomized multicentre
study with 5-year follow-up. Eur Urol Suppl 2006; 5:310.
16. Mattiasson A, Wargrell L, Schelin S, et al. Five-year follow-up of
feedback microwave thermotherapy versus TURP for clinical BPH: a
prospective randomized multicentre study. Urology 2007; 69:91-96.
17. Tsai YS, Lin JSN, Tong YC, et al. Transurethral microwave thermotherapy
for symptomatic benign prostatic hyperplasia: Long term
durability with Prostcare. Eur Urol 2001; 39:688-694.
18. Terada N, Aoki Y, Ichioka K, et al. Microwave thermotherapy for
benign prostatic hyperplasia with the Dornier Urowave: response
durability and variables potentially predicting response. Urology 2001;
57:701-706.
19. Ekstrand V, Westermark S, Wiksell H, et al. Long-term clinical
outcome of transurethral microwave thermotherapy (TUMT) 1991-
7° Congresso Nazionale Associazione Italiana di Endourologia
1999 at Karolinska Hospital, Sweden. Scand J Urol Nephrol 2002;
36: 113-118.
20. Trock BJ, Brotzman M, Utz WJ, et al. Long-term pooled analysis of
multicenter studies of cooled thermotherapy for benign prostatic hyperplasia
results at three months through four years. Urology 2004; 63:
716-721.
21. Bruskewitz, R., Issa, M. M., Roehrborn, C. G., et al. A prospective,
randomized 1-year clinical trial comparing transurethral needle ablation
to transurethral resection of the prostate for the treatment of symptomatic
benign prostatic obstruction. J Urol 1998; 159: 1588.
22. Fitzpatrick JM, Mebust WK. Minimally invasive and endoscopic
management of benign prostatic obstruction. In Walsh PC, Retik AB,
Vaughn ED, Wein AJ eds. Campbell's Urology, 8th ed. Philadelphia:
WB Saunders, 2002: 1379-1422.
23. Hill B, Bel Ville W, Bruskewitz R, et al. Transurethral needle ablation
versus transurethral resection of the prostate for the treatment of
symptomatic benign prostatic obstruction: 5-year results of a prospective,
randomized, multicentre clinical trial. J Urol 2004; 171(6, Part 1
of 2):2336-2340.
24. Cimentepe E, Unsal A, Saglam R. Randomized clinical trial comparing
transurethral needle ablation with transurethral resection of the
prostate for the treatment of benign prostatic obstruction: results at 18
months. J Endourol 2003; 17:103–107.
25. Boyle P, Robertson C, Vaughan ED, Fitzpatrick JM. A metanalysis
of trials of trnasurethral needle ablation for treating symptomatic
benign prostatic obstruction. Br J Urol Int 2004; 94(1):83-88.
26. Chandrasekar P, Virdi JS. Transurethral needle ablation of the
prostate (TUNA) – a prospective study, six year follow-up. AUA Annual
Meeting Clinical Abstracts. Lippincott, Williams & Wilkins, 2001.
27. Steele GS and Sleep, DJ. Transurethral needle ablation of the
prostate: An urodynamically based study with 2-year follow up. J Urol
1997; 158:1834.
28. Schatzl G, Madersbacher S, Djavan B, et al. Two-year results of
transurethral resection of the prostate versus four ‘less invasive’ treatment
options. Eur Urol 2000; 37:695–701.
29. Zlotta AR, Giannakopoulos X, Maehlum O, Ostrem T, Schulman
CC. Long-term evaluation of transurethral needle ablation of the
prostate (TUNA) for treatment of symptomatic benign prostatic
obstruction: clinical outcome up to five years from three centers. Eur
Urol 2003; 44: 89–93.
30. Namiki K, Shiozawa H, Tsuzuki M, et al. Efficacy of transurethral
needle ablation of the prostate for the treatment of benign prostatic
obstruction. Int J Urol 1999; 6:341–345.
31. Kahn SA, Alphonse P, Tewari A, Narayan P. An open study on the
efficacy and safety of transurethral needle ablation of the prostate in
treating symptomatic benign prostatic obstruction: the University of
Florida experience. J Urol 1998; 160: 1695–1700.
32. Naslund MJ, Benson RC, Cohen ES, Gutierrez-Aceves J, Issa
MM. Transurethral needle ablation (TUNA) for BPO in patients with
median lobe enlargement. Report of a prospective multicentre study.
AUA Annual Meeting Clinical Abstracts. Lippincott, Williams &
Wilkins, 2000.
33. Bergamaschi F, Manzo M, Autieri G, Corrada P, Campo B. Five
years experience using transurethral needle ablation (TUNA) in 204
BPO patients. AUA Annual Meeting Clinical Abstracts. Lippincott,
Williams & Wilkins, 2000.
34. Apostolos A, George M, Dimitrios A, George D, Ioannis C. Longterm
efficacy and safety of transurethral needle ablation of the prostate
(TUNA) for bladder outlet obstruction of prostatic origin: five-year
experience. Eur Urol 2002; 40 (Suppl 1):129.
Archivio Italiano di Urologia e Andrologia 2007, 79, 3, Supplemento 1
51